[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3876 Introduced in House (IH)]






108th CONGRESS
  2d Session
                                H. R. 3876

 To amend part C of title XVIII of the Social Security Act to prohibit 
  the comparative cost adjustment (CCA) program from operating in the 
                           State of Florida.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 2, 2004

Mr. Hastings of Florida (for himself, Mr. Wexler, Mr. Davis of Florida, 
 Mr. Boyd, Mr. Meek of Florida, Ms. Corrine Brown of Florida, and Mr. 
   Deutsch) introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend part C of title XVIII of the Social Security Act to prohibit 
  the comparative cost adjustment (CCA) program from operating in the 
                           State of Florida.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROHIBITION ON OPERATION OF MEDICARE COMPARATIVE COST 
              ADJUSTMENT (CCA) PROGRAM IN FLORIDA.

    (a) In General.--Section 1860C-1(b) of the Social Security Act, as 
added by section 241 of the Medicare Prescription Drug, Improvement, 
and Modernization Act of 2003 (Public Law 108-173), is amended by 
adding at the end the following:
            ``(3) No cca areas within florida.--A CCA area shall not 
        include an MSA any portion of which is within the State of 
        Florida.''.
    (b) Effective Date.--The amendment made by this section shall take 
effect as if included in the enactment of the Medicare Prescription 
Drug, Improvement, and Modernization Act of 2003 (Public Law 108-173).
                                 <all>